Failure of fixation is a common problem in the treatment of osteoporotic fractures around the hip. The reinforcement of bone stock or of fixation of the implant may be a solution. Our study assesses the existing evidence for the use of bone substitutes in the management of these fractures in osteoporotic patients. Relevant publications were retrieved through Medline research and further scrutinised. Of 411 studies identified, 22 met the inclusion criteria, comprising 12 experimental and ten clinical reports. The clinical studies were evaluated with regard to their level of evidence. Only four were prospective and randomised.Polymethylmethacrylate and calcium-phosphate cements increased the primary stability of the implant-bone construct in all experimental and clinical studies, although there was considerable variation in the design of the studies. In randomised, controlled studies, augmentation of intracapsular fractures of the neck of the femur with calcium-phosphate cement was associated with poor long-term results. There was a lack of data on the longterm outcome for trochanteric fractures. Because there were only a few, randomised, controlled studies, there is currently poor evidence for the use of bone cement in the treatment of fractures of the hip.With the steadily increasing proportion of elderly people in the population, osteoporosis, a disease process characterised by compromised bone strength predisposing to an increased risk of fracture, will become epidemic. By 2012, 25% of people living in Europe will be older than 65 years 1 and more than 40% of women and 14% of men over the age of 50 years will sustain osteoporotic fractures.2 Common sites affected by osteoporotic fractures include the wrist, spine, ribs, humerus and the proximal femur.